Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics

B Mubeen, AN Ansar, R Rasool, I Ullah, SS Imam… - Antibiotics, 2021 - mdpi.com
The emergence of infectious diseases promises to be one of the leading mortality factors in
the healthcare sector. Although several drugs are available on the market, newly found …

Surgical antibiotic prophylaxis in an era of antibiotic resistance: common resistant bacteria and wider considerations for practice

BD Menz, E Charani, DL Gordon… - Infection and Drug …, 2021 - Taylor & Francis
The increasing incidence of antimicrobial resistance (AMR) presents a global crisis to
healthcare, with longstanding antimicrobial agents becoming less effective at treating and …

High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal

NP Parajuli, SP Acharya, SK Mishra, K Parajuli… - … Resistance & Infection …, 2017 - Springer
Background Healthcare associated infections (HCAI) and antimicrobial resistance are
principal threats to the patients of intensive care units and are the major determining factors …

Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt

ES Mohamed, RMM Khairy, SS Abdelrahim - Antimicrobial Resistance & …, 2020 - Springer
Abstract Background Infections caused by Enterobacteriaceae are mainly treated with the β-
lactam antibiotics, nevertheless, the emergence of species with plasmid-borne β-lactamases …

Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria

RG D'Angelo, JK Johnson, JT Bork… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Extended spectrum β-lactamases (ESBL) and AmpC β-lactamases are
increasing causes of resistance in many Gram-negative pathogens of common infections …

Prevalence and Risk Factors for ESBL/AmpC-E. coli in Pre-Weaned Dairy Calves on Dairy Farms in Germany

LP Weber, S Dreyer, M Heppelmann, K Schaufler… - Microorganisms, 2021 - mdpi.com
The objectives of this study were to ascertain the fecal ESBL/AmpC-E. coli prevalence and to
detect risk factors for their occurrence in young pre-weaned calves and their dams on large …

[HTML][HTML] Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates

H Kazemian, H Heidari, R Ghanavati… - Medical Principles and …, 2019 - karger.com
Objectives: Drug resistance among gram-negative bacteria is a worldwide challenge. Due to
the importance of drug-resistant Klebsiella pneumoniae and Escherichia coli strains in …

Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories …

SG Tekele, DS Teklu, KD Tullu, SK Birru, MH Legese - PLoS One, 2020 - journals.plos.org
Background Extended spectrum Beta-lactamases (ESBLs) and AmpC beta-lactamases
(AmpC) are the common enzymes produced by gram negative bacilli, which are their main …

Genotypic and Phenotypic Detection of AmpC β-lactamases in Enterobacter spp. Isolated from a Teaching Hospital in Malaysia

FI Mohd Khari, R Karunakaran, R Rosli, S Tee Tay - PloS one, 2016 - journals.plos.org
Objectives The objective of this study was to determine the occurrence of chromosomal and
plasmid-mediated β-lactamases (AmpC) genes in a collection of Malaysian isolates of …

[HTML][HTML] Carriage of beta-lactamase-producing Enterobacteriaceae among nursing home residents in north Lebanon

I Dandachi, ES Sokhn, E Najem, E Azar… - International journal of …, 2016 - Elsevier
Summary Background Multidrug-resistant (MDR) Enterobacteriaceae can cause severe
infections with high morbidity, mortality, and health care costs. Individuals can be fecal …